Hologic has introduced two new respiratory assays, the Panther Fusion SARS-CoV-2/Flu A/B/RSV assay and Novodiag RESP-4 molecular diagnostic test, in the European Union (EU).
The two assays have been designed for the detection and differentiation of four respiratory viruses that can have similar clinical symptoms, namely influenza A (Flu A), influenza B (Flu B), SARS-CoV-2 and respiratory syncytial virus (RSV).
The company stated that these assays are compliant with the European In Vitro Diagnostic Medical Device Directive (IVDD) and are being made available in time for the respiratory viral season in the Northern Hemisphere.
